Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM3 | Q86V86 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
| ▸ | F9 | P00740 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19845507 | 0.97 | PIM3 (0.33) | PIM3KDM4EATML3MBTL1ALOX5 | |
| SCHEMBL19845471 | 0.96 | PIM3 (0.35) | PIM3KDM4EATML3MBTL1ALOX5 | |
| SCHEMBL21795220 | 0.94 | KDM4E (0.38) | PIM3KDM4EATML3MBTL1ALOX5 | |
| SCHEMBL15786079 | 0.94 | KDM4E (0.37) | PIM3KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL19845463 | 0.94 | PIM3 (0.37) | PIM3KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL19845509 | 0.93 | PIM3 (0.33) | PIM3KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL19845479 | 0.93 | PIM3 (0.36) | PIM3KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL19845460 | 0.93 | PIM3 (0.37) | PIM3KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL15786080 | 0.93 | KDM4E (0.38) | PIM3KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL18565680 | 0.93 | KDM4E (0.36) | PIM3KDM4EATML3MBTL1PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | PIEZO1, ETV6, LEF1 | PIM3 1744/4885KDM4E 2538/4885ATM 3035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.